Swedish Orphan Biovitrum (BIOVF) Short Interest Ratio & Short Volume $29.79 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock Swedish Orphan Biovitrum Short Interest DataSwedish Orphan Biovitrum (BIOVF) has a short interest of 317,500 shares. This marks a -60.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3,175.0, indicating that it would take 3,175.0 days of the average trading volume of 65 shares to cover all short positions.Current Short Interest317,500 sharesPrevious Short Interest805,300 sharesChange Vs. Previous Month-60.57%Dollar Volume Sold Short$9.29 millionShort Interest Ratio3,175.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares356,000,000 sharesPercentage of Shares Shorted0.09%Today's Trading Volume0 sharesAverage Trading Volume65 sharesToday's Volume Vs. Average0% Short Selling Swedish Orphan Biovitrum? Sign up to receive the latest short interest report for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIOVF Short Interest Over TimeBIOVF Days to Cover Over TimeBIOVF Percentage of Float Shorted Over Time Swedish Orphan Biovitrum Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025317,500 shares $9.29 million -60.6%N/A3175 $29.25 6/30/2025805,300 shares $23.56 million -17.7%0.2%4026.5 $29.25 6/15/2025978,400 shares $31.30 million +4.8%0.3%9784 $31.99 5/31/2025933,300 shares $28.27 million +3.0%0.3%1166.6 $30.29 5/15/2025906,600 shares $27.65 million -11.4%0.3%4533 $30.50 4/30/20251,023,100 shares $31.36 million -16.6%N/A10231 $30.66 4/15/20251,227,000 shares $33.01 million +9.6%0.3%1752.9 $26.90 3/31/20251,119,800 shares $32.15 million +43.6%0.3%11198 $28.71 3/15/2025779,800 shares $23.39 million +35.9%0.2%7798 $29.99 2/28/2025573,800 shares $17.04 million +0.3%0.2%5738 $29.70 Get the Latest News and Ratings for BIOVF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025572,000 shares $17.43 million -11.0%0.2%5720 $30.48 1/31/2025642,400 shares $19.58 million -55.7%N/A6424 $30.48 1/15/20251,450,700 shares $41.05 million +5.3%N/A14507 $28.30 12/31/20241,377,300 shares $38.10 million -7.9%N/A13773 $27.66 12/15/20241,494,600 shares $42.78 million -1.5%N/A7473 $28.62 11/30/20241,517,000 shares $41.31 million -10.2%N/A15170 $27.23 11/15/20241,688,500 shares $52.99 million +90.3%N/A16885 $31.38 10/31/2024887,500 shares $28.41 million -14.6%N/A8875 $32.01 10/15/20241,038,600 shares $30.64 million +33.0%N/A10386 $29.50 9/30/2024780,900 shares $24.45 million -31.5%N/A2603 $31.31 9/15/20241,139,700 shares $35.65 million +3.0%N/A1628.1 $31.28 8/31/20241,107,000 shares $34.63 million -9.6%N/A11070 $31.28 8/15/20241,224,400 shares $29.48 million -4.1%N/A3061 $24.08 7/31/20241,276,900 shares $34.74 million -4.9%N/A1418.8 $27.21 7/15/20241,342,000 shares $35.58 million -5.1%N/A4473.3 $26.51 6/30/20241,414,600 shares $38.13 million -5.1%N/A4715.3 $26.96 6/15/20241,490,900 shares $39.26 million -1.6%N/A3727.2 $26.33 5/31/20241,514,400 shares $39.00 million -4.8%N/A0 $25.76 5/15/20241,591,500 shares $40.99 million +36.9%N/A2273.6 $25.76 4/30/20241,162,200 shares $26.58 million +48.9%N/A1937 $22.87 4/15/2024780,600 shares $19.52 million +6.3%N/A7806 $25.00 3/31/2024734,400 shares $19.79 million +9.8%N/A3672 $26.95 3/15/2024669,100 shares $18.59 million +3.8%N/A6691 $27.79 2/29/2024644,500 shares $15.31 million +18.7%N/A6445 $23.75 2/15/2024543,100 shares $12.67 million +27.6%N/A5431 $23.32 1/15/2024456,200 shares $12.32 million -17.1%N/A1520.7 $27.00 12/31/2023550,100 shares $14.44 million -4.1%N/A2957.4 $26.25 12/15/2023573,800 shares $13.28 million +2.6%N/A2869 $23.15 11/30/2023559,200 shares $11.77 million -1.4%N/A5592 $21.05 11/15/2023567,000 shares $11.94 million -0.7%N/A2835 $21.05BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 10/31/2023570,700 shares $11.57 million +8.5%N/A1426.8 $20.27 10/15/2023526,200 shares $10.94 million +15.7%N/A5262 $20.80 9/30/2023454,900 shares $9.46 million +11.3%N/A2274.5 $20.80 9/15/2023408,800 shares $8.16 million +33.9%N/A4088 $19.95 8/31/2023305,200 shares $5.98 million +34.9%N/A953.6 $19.61 8/15/2023226,200 shares $4.38 million +16.8%N/A2262 $19.35 7/31/2023193,700 shares $3.83 million +12.2%N/A1937 $19.75 7/15/2023172,600 shares $3.36 million +0.9%N/A575.3 $19.45 6/30/2023171,100 shares $3.64 million +3.7%N/A1711 $21.25 6/15/2023165,000 shares $3.51 million +23.7%N/A1650 $21.25 5/31/2023133,400 shares $2.66 million +33.4%N/A190.6 $19.92 5/15/2023100,000 shares $2.19 million -66.2%N/A200 $21.89 4/30/2023295,900 shares $7.81 million +0.6%N/A2959 $26.40 4/15/2023294,100 shares $7.79 million -9.7%N/A735.3 $26.48 3/31/2023325,500 shares $7.52 million +1.6%N/A813.8 $23.11 3/15/2023320,400 shares $7.29 million -28.4%N/A3204 $22.74 2/28/2023447,200 shares $10.08 million +41.6%N/A1118 $22.55 2/15/2023315,900 shares $7.49 million +3.9%N/A263.3 $23.70 1/31/2023304,000 shares $6.88 million +31.7%N/A1013.3 $22.63 1/15/2023230,800 shares $5.05 million +6.0%N/A177.5 $21.89 12/30/2022217,700 shares $4.60 million -48.6%N/A1088.5 $21.15 12/15/2022423,200 shares $8.95 million +237.8%N/A4232 $21.15 11/30/2022125,300 shares $2.65 million -72.4%N/A1253 $21.15 11/15/2022454,000 shares $8.80 million +6.3%N/A12 $19.38 10/31/2022427,000 shares $7.79 million +9.6%N/A4270 $18.25 10/15/2022389,600 shares $7.11 million -1.3%N/A354.2 $18.25 9/30/2022394,700 shares $7.33 million -1.9%N/A657.8 $18.58 9/15/2022402,500 shares $8.33 million +4.9%N/A4025 $20.70 8/31/2022383,600 shares $8.67 million +2.4%N/A1918 $22.60 8/15/2022374,700 shares $8.74 million +0.2%N/A3747 $23.33 7/31/2022373,900 shares $7.93 million +16.7%N/A3739 $21.20 7/15/2022320,300 shares $6.79 million -3.2%N/A3203 $21.20 6/30/2022330,900 shares $7.25 million -37.8%N/A1654.5 $21.92 6/15/2022532,100 shares $10.83 million -0.1%N/A5321 $20.36 5/31/2022532,500 shares $11.56 million -37.9%N/A760.7 $21.70 5/15/2022856,900 shares $17.14 million +34.6%N/A4284.5 $20.00 4/30/2022636,600 shares $13.43 million +4.7%N/A3183 $21.10 4/15/2022607,800 shares $14.70 million -3.2%N/A1215.6 $24.18 3/31/2022628,000 shares $14.29 million -2.7%N/A2093.3 $22.75 3/15/2022645,600 shares $12.91 million +13.3%N/A6456 $20.00 2/28/2022569,900 shares $11.65 million -0.6%N/A5699 $20.45 2/15/2022573,200 shares $11.83 million -2.3%N/A1433 $20.64 1/31/2022586,800 shares $11.15 million +818.3%N/A5868 $19.00 1/15/202263,900 shares $1.30 million -14.2%N/A319.5 $20.30 12/31/202174,500 shares $1.52 million +4.5%N/A248.3 $20.39 12/15/202171,300 shares $1.41 million -87.7%N/A44.6 $19.76 11/30/2021581,600 shares $14.53 million +500.8%N/A5816 $24.99 11/15/202196,800 shares $2.54 million -8.0%N/A322.7 $26.25 10/29/2021105,200 shares $2.82 million +3.8%N/A116.9 $26.81 10/15/2021101,400 shares $2.75 million -75.3%N/A26.7 $27.13BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 9/30/2021410,200 shares $11.21 million -17.5%N/A141.4 $27.33 9/15/2021497,100 shares $13.95 million +10.5%N/A113 $28.06 8/31/2021449,900 shares $9.90 million -40.3%N/A86.5 $22.00 8/13/2021753,300 shares $14.52 million -23.7%N/A2511 $19.28 7/30/2021987,500 shares $19.83 million -0.1%N/A548.6 $20.08 7/15/2021988,900 shares $18.79 million -8.6%N/A9889 $19.00 6/30/20211,081,900 shares $19.67 million +3.4%N/A3606.3 $18.18 6/15/20211,046,200 shares $20.77 million -5.8%N/A317 $19.85 5/28/20211,110,500 shares $17.82 million -0.5%N/A1586.4 $16.05 5/14/20211,115,800 shares $18.41 million -42.1%N/A5579 $16.50 4/30/20211,925,300 shares $33.31 million +0.2%N/A3850.6 $17.30 4/15/20211,920,600 shares $32.56 million +37.8%N/A19206 $16.96 3/31/20211,394,000 shares $21.61 million +5.4%N/A2323.3 $15.50 3/15/20211,322,600 shares $23.03 million -2.2%N/A2204.3 $17.41 2/26/20211,352,200 shares $22.58 million +44.1%N/A1502.4 $16.70 2/12/2021938,500 shares $18.77 million +17.5%N/A1877 $20.00 1/29/2021798,700 shares $14.91 million +34.6%N/A998.4 $18.67 1/15/2021570,400 shares $11.34 million +4.1%N/A1426 $19.88 12/31/2020618,300 shares $12.09 million +8.4%N/A6183 $19.55 12/15/2020570,400 shares $11.30 million +4.1%N/A1426 $19.81 11/30/2020548,000 shares $9.78 million -18.3%N/A548 $17.85 11/15/2020670,700 shares $12.37 million +4.5%N/A958.1 $18.44 10/30/2020642,100 shares $10.77 million -27.4%N/A237.8 $16.77 10/15/2020884,000 shares $18.21 million +120.8%N/A1473.3 $20.60 9/30/2020400,300 shares $9.71 million -62.7%N/A400.3 $24.25 9/15/20201,074,400 shares $26.59 million +5.6%N/A2686 $24.75 8/31/20201,017,800 shares $22.70 million +1.7%N/A1272.3 $22.30 8/14/20201,001,100 shares $22.02 million -2.2%N/A667.4 $22.00 BIOVF Short Interest - Frequently Asked Questions What is Swedish Orphan Biovitrum's current short interest? Short interest is the volume of Swedish Orphan Biovitrum shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 317,500 shares of BIOVF short. Learn More on Swedish Orphan Biovitrum's current short interest. What is a good short interest ratio for Swedish Orphan Biovitrum? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOVF shares currently have a short interest ratio of 3,175.0. Learn More on Swedish Orphan Biovitrum's short interest ratio. Is Swedish Orphan Biovitrum's short interest increasing or decreasing? Swedish Orphan Biovitrum saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 317,500 shares, a drop of 60.6% from the previous total of 805,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Swedish Orphan Biovitrum's short interest compare to its competitors? Here is how the short interest of companies in the industry of "med - biomed/gene" compare to Swedish Orphan Biovitrum: argenex SE (2.94%), BioNTech SE Sponsored ADR (2.55%), Royalty Pharma PLC (5.04%), Insmed, Inc. (5.11%), Biogen Inc. (2.67%), Sino Biopharmaceutical (0.11%), Illumina, Inc. (4.98%), Incyte Corporation (3.73%), Genmab A/S (0.11%), Genmab A/S Sponsored ADR (0.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Swedish Orphan Biovitrum stock? Short selling BIOVF is an investing strategy that aims to generate trading profit from Swedish Orphan Biovitrum as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Swedish Orphan Biovitrum? A short squeeze for Swedish Orphan Biovitrum occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOVF, which in turn drives the price of the stock up even further. How often is Swedish Orphan Biovitrum's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOVF, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies argenex Short Interest Data BioNTech Short Interest Data Royalty Pharma Short Interest Data Insmed Short Interest Data Biogen Short Interest Data Sino Biopharmaceutical Short Interest Data Illumina Short Interest Data Incyte Short Interest Data Genmab A/S Short Interest Data Genmab A/S Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BIOVF) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Swedish Orphan Biovitrum Please log in to your account or sign up in order to add this asset to your watchlist. Share Swedish Orphan Biovitrum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOVF Stock Alerts